| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 |
| filingDate |
2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237aeb93a1724c0ed17f206e47256650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff84c2fd51ff2c61635a0c2b96da749b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17090e6f59957f872448aaae172e7a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df0b8ef864bd1a12a29b26efabf880e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9647957104688f813322128f09f18fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aecf882f2c3c3ae5f0013a7d71d8cc38 |
| publicationDate |
2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-331989-B1 |
| titleOfInvention |
Aqueous intravenous infusion solution and intravenous infusion concentrate comprising levosimendan. |
| abstract |
An invention is described which relates to levosimendan solutions for pharmaceutical use, and in particular to intravenous administration. The solution of the invention has enhanced stability and is particularly useful as infusion solutions or injection solutions or concentrates. Levosimendan is useful in the treatment of congestive heart failure. |
| priorityDate |
1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |